Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloidosis Transthyretin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03997383
What this trial is testing

APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)

Who this might be right for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Alnylam Pharmaceuticals 360
Not applicableStudy completedNCT03352089
What this trial is testing

Positron Emission Tomography / Magnetic Resonance Imaging in Aortic Stenosis

Who this might be right for
Aortic StenosisTransthyretin Amyloidosis
University of Edinburgh 22
Not applicableStudy completedNCT03720275
What this trial is testing

Early and Systematic Screening in Chronic Neuropathy

Who this might be right for
Amyloid Neuropathies, Familial
University Hospital, Bordeaux 130
Not applicableStudy completedNCT06073574
What this trial is testing

CARDIO-TTRansform Magnetic Resonance Imaging (MRI) Sub-study

Who this might be right for
Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Ionis Pharmaceuticals, Inc. 160
Not applicableUnknownNCT05701410
What this trial is testing

Prevalence of Cardiac Amyloidosis Among Patients With a History of Lumbar Spinal Stenosis.

Who this might be right for
Cardiac AmyloidosisSpinal Stenosis
Steen Hvitfeldt Poulsen 200
Not applicableStudy completedNCT03812172
What this trial is testing

Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations

Who this might be right for
Amyloid Cardiomyopathy, Transthyretin-Related
Mathew S. Maurer, MD 646
Not applicableUnknownNCT02260466
What this trial is testing

Prevalence and Post-surgical Outcomes of CARdiac Wild-type TransthyrEtin amyloidoSIs in Elderly Patients With Aortic steNosis Referred for Valvular Replacement.

Who this might be right for
Heart DiseaseAgingAmyloidosis+1 more
French Cardiology Society 186
Testing effectiveness (Phase 2)Looking for participantsNCT07829705
What this trial is testing

Beta-amyloid PET/CT to Measure Potential Therapeutic Response in AL-CA

Who this might be right for
Light Chain Cardiac Amyloidosis
Peking Union Medical College Hospital 60
Not applicableStudy completedNCT04801329
What this trial is testing

Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid Cardiomyopathy

Who this might be right for
ATTR-CM (Transthyretin Amyloid Cardiomyopathy)
Pfizer 110
Not applicableStudy completedNCT05693376
What this trial is testing

Screening Algorithm for Early Detection of Occult Cardiac Amyloidosis

Who this might be right for
Cardiac Amyloidosis
University Hospital, Essen 85
Not applicableNot Yet RecruitingNCT07605741
What this trial is testing

Fast Cardiac Bone SPECT-CZT in Transthyretin Cardiac Amyloidosis

Who this might be right for
Cardiac Amyloidosis
Central Hospital, Nancy, France 200
Not applicableLooking for participantsNCT05444920
What this trial is testing

The Italian Transthyretin Amyloidosis Web-Network

Who this might be right for
ATTR Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 1,000
Not applicableNot Yet RecruitingNCT07494942
What this trial is testing

Impact of a Cardiac Rehabilitation Program on Patients With Cardiac Amyloidosis

Who this might be right for
Amyloidosis
University Hospital, Montpellier 40
Large-scale testing (Phase 3)Study completedNCT02510261
What this trial is testing

The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Participants Who Have Already Been Treated With ALN-TTR02 (Patisiran)

Who this might be right for
Amyloidosis
Alnylam Pharmaceuticals 211
Not applicableLooking for participantsNCT06907186
What this trial is testing

An Interventional Pilot Study to Investigate the Feasibility and Acceptance of a Structured Psychological Support Program for Patients, Caregivers, and Presymptomatic Carriers in Hereditary Transthyretin Amyloidosis With Cardiomyopathy

Who this might be right for
Hereditary Transthyretin Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia 150
Not applicableLooking for participantsNCT02798705
What this trial is testing

Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis

Who this might be right for
Cardiac Amyloidosis
Samsung Medical Center 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT07213583
What this trial is testing

Study of Re-Treatment With ALXN2220 in Patients With ATTR-CM

Who this might be right for
Amyloid Transthyretin Cardiomyopathy
Neurimmune AG 35
Not applicableActive Not RecruitingNCT06257485
What this trial is testing

Bronx Transthyretin Amyloid Cardiomyopathy Database

Who this might be right for
Transthyretin Cardiac AmyloidosisTransthyretin Amyloid Cardiomyopathy
Montefiore Medical Center 476
Large-scale testing (Phase 3)Enrolling By InvitationNCT06679946
What this trial is testing

Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

Who this might be right for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Alnylam Pharmaceuticals 700
Not applicableLooking for participantsNCT07172243
What this trial is testing

BE.Amycon Biobank & Data Registry UZ Leuven

Who this might be right for
AmyloidosisAL AmyloidosisAmyloidosis Cardiac
Universitaire Ziekenhuizen KU Leuven 505
Next Page